Jun. 12 at 3:10 PM
$TENX
Piper raising PT from
$20 →
$50.
Price also pushing off the 200DMA today, showing early strength after the recent base.
Catalyst ahead: Phase 3 data in Q3 (likely late Aug-Sept).
Enrollment completed in March, with a ~12-week study window, meaning last patient dosing likely wraps in July. Data window is getting closer.
This is a classic setup where price starts moving ahead of a binary catalyst - but volatility will likely expand into readout.
